CHOROIDAL NEOVASCULARIZATION
Clinical trials for CHOROIDAL NEOVASCULARIZATION explained in plain language.
Never miss a new study
Get alerted when new CHOROIDAL NEOVASCULARIZATION trials appear
Sign up with your email to follow new studies for CHOROIDAL NEOVASCULARIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Vision-Saving drug challenges standard treatment for blinding eye disease
Disease control Not yet recruitingThis study is testing whether a new eye injection called tiespectus works as well as the current standard treatment (aflibercept) for wet age-related macular degeneration, a leading cause of vision loss in older adults. Researchers will enroll 960 people who haven't received trea…
Matched conditions: CHOROIDAL NEOVASCULARIZATION
Phase: PHASE2, PHASE3 • Sponsor: EyeBiotech Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:16 UTC
-
New eye injection strategy aims to halt rapid vision loss
Disease control Not yet recruitingThis study is testing if a medication called faricimab, given as eye injections, can better control a severe and fast-progressing type of age-related macular degeneration (AMD). Researchers want to see if using a specific, careful treatment schedule can preserve vision and preven…
Matched conditions: CHOROIDAL NEOVASCULARIZATION
Phase: PHASE4 • Sponsor: Kim's Eye Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC